Long-chain FAHFAs exert antiinflammatory, antioxidant, and antidiabetic functions, possibly by acting on GPR40 or GPR120 (63, 64), and AAHFAs — likely produced by gut microbiota (62) — are inversely correlated with metabolic disease (61). This evidence concerns the gene FFAR1 and metabolic disease.